|
FNTB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.968400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.040400E-03 |
| Normal-vs-Stage2 |
9.755000E-01 |
| Normal-vs-Stage3 |
8.447600E-01 |
| Normal-vs-Stage4 |
6.956800E-01 |
| Stage1-vs-Stage2 |
7.162300E-02 |
| Stage1-vs-Stage3 |
2.214300E-02 |
| Stage1-vs-Stage4 |
1.063870E-02 |
| Stage2-vs-Stage3 |
9.170400E-01 |
| Stage2-vs-Stage4 |
7.558600E-01 |
| Stage3-vs-Stage4 |
6.092800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.783800E-01 |
| Normal-vs-AfricanAmerican |
1.303600E-01 |
| Normal-vs-Asian |
3.89410000000145E-05 |
| Caucasian-vs-AfricanAmerican |
4.298600E-01 |
| Caucasian-vs-Asian |
1.861860E-02 |
| AfricanAmerican-vs-Asian |
4.561900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.954200E-01 |
| Normal-vs-Female |
3.069800E-02 |
| Male-vs-Female |
1.963600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.439600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.142200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.385800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.919600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.556200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.905600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.657200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.050190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.621960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.261000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.50439999241559E-09 |
| Normal-vs-Grade 2 |
1.162370E-02 |
| Normal-vs-Grade 3 |
6.167200E-01 |
| Normal-vs-Grade 4 |
3.683600E-01 |
| Grade 1-vs-Grade 2 |
6.203100E-04 |
| Grade 1-vs-Grade 3 |
1.239480E-04 |
| Grade 1-vs-Grade 4 |
3.55650000000152E-05 |
| Grade 2-vs-Grade 3 |
5.285500E-02 |
| Grade 2-vs-Grade 4 |
6.238600E-03 |
| Grade 3-vs-Grade 4 |
2.167200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.010000E-02 |
| Normal-vs-ccB subtype |
4.406200E-01 |
| ccA subtype-vs-ccB subtype |
1.768960E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.129180E-01 |
| Normal-vs-N1 |
3.639000E-01 |
| N0-vs-N1 |
1.564570E-01 |
|
|
